SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-09-000742
Filing Date
2009-03-13
Accepted
2009-03-13 17:07:39
Documents
22
Effectiveness Date
2009-03-13

Document Format Files

Seq Description Document Type Size
1 dfan14a07422003_03132009.htm DFAN14A 47205
2 contact.jpg GRAPHIC 31783
3 slide1.jpg GRAPHIC 43094
4 slide2.jpg GRAPHIC 61208
5 slide3.jpg GRAPHIC 64654
6 slide4.jpg GRAPHIC 62431
7 slide5.jpg GRAPHIC 74474
8 slide6.jpg GRAPHIC 77132
9 slide7.jpg GRAPHIC 87783
10 slide8.jpg GRAPHIC 73594
11 slide9.jpg GRAPHIC 71017
12 slide10.jpg GRAPHIC 52798
13 slide11.jpg GRAPHIC 104051
14 slide12.jpg GRAPHIC 89722
15 slide13.jpg GRAPHIC 81092
16 slide14.jpg GRAPHIC 79686
17 slide15.jpg GRAPHIC 81291
18 slide16.jpg GRAPHIC 87826
19 slide17.jpg GRAPHIC 80780
20 slide18.jpg GRAPHIC 72026
21 slide19.jpg GRAPHIC 103873
22 slide20.jpg GRAPHIC 59555
  Complete submission text file 0000921895-09-000742.txt   2173241
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A
SIC: 6282 Investment Advice

Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Subject) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: DFAN14A | Act: 34 | File No.: 000-28272 | Film No.: 09681031
SIC: 2835 In Vitro & In Vivo Diagnostic Substances